Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
120 Leser
Artikel bewerten:
(0)

Pharmapod Partners With FIP to Improve Patient Safety

AMMAN, Jordan, April 25, 2019 /PRNewswire/ -- The International Pharmaceutical Federation (FIP) and Pharmapod have today signed a partnership, to offer an infrastructure for effective incident management and continuous quality improvement for pharmacists internationally.

Pharmapod Logo (PRNewsfoto/Pharmapod)

Medication errors are a significant global problem, impacting millions of lives daily. In response to the World Health Organization's Patient Safety Challenge to reduce these errors by 50% over the next 5 years, pharmacists as medication experts are taking a lead role in developing and adopting effective solutions to improve processes across the healthcare system and prevent patient harm.

Pharmapod are driving worldwide change in patient safety with its Global Learning Health System. This is an award-winning, professionally-led solution which has rolled out across pharmacies, hospitals and long-term care facilities internationally - for example, it is the mandated system for the largest medication safety program of its kind in Canada, involving over 4,500 pharmacies.

The system helps drive improvements in quality and efficiencies in process, which are demonstrable and measurable for healthcare professionals. In addition to incorporating artificial intelligence tools such as machine learning into its technology, Pharmapod are now also connecting experts in medication safety internationally through establishing national response teams in each country to analyse the medication error data and develop improvement strategies.

FIP is recognised as the leader of pharmacy at a global level. Through its 144 membership organisations, its academic institutional members and individual members, it represents over four million pharmacists and pharmaceutical scientists around the world. FIP continues to expand its presence within pharmacy, the pharmaceutical sciences and pharmacy education, and to influence the pharmacy profession through partnerships with some of the world's leading health, policymaking, education and science institutions.

"The shared aims and goals of our two organisations provide the perfect environment to formalise existing collaborations and joint working, which is an important step forward for Pharmapod and FIP, now and in the future. Having two international organisations working in mutually beneficial and positive ways provides an excellent framework for similar collaborations at local levels, which we will both support and encourage through our agreed work programmes in FIP Education, specifically our Workforce Development Hub. We look forward to working closely with our global partners, commonwealth partners and member organisations," said FIP CEO Catherine Duggan.

Pharmapod CEO Leonora O'Brien added: "Being a pharmacist myself, it is a particular honour to collaborate with FIP and contribute to our profession. Given their unique remit, the FIP team has a 360 view on international pharmacy practice which is very exciting for us. We share a global vision and our professional goals and values are aligned. Pharmacists in every country provide an extraordinary service to their public. By harnessing technology, we can strengthen communications across the profession, helping pharmacists share their expertise and accelerate improvements in practice. To improve our health systems, we have to progress from the existing 'walled gardens' - we need to be able to share data and learn from each other. This is what Pharmapod's partnership with FIP aims to achieve."

For more information on Pharmapod, visit https://www.pharmapodhq.com.

Logo: https://mma.prnewswire.com/media/811918/Pharmapod_Logo.jpg

© 2019 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.